Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy
Status:
Completed
Trial end date:
2020-04-27
Target enrollment:
Participant gender:
Summary
This phase II study is to evaluate the safety and efficacy of Ferinject® in reducing
perioperative transfusion in iron deficiency anemia patients anticipating
pancreatoduodenectomy.